Cargando…
Novel Phenobarbital-Loaded Nanostructured Lipid Carriers for Epilepsy Treatment: From QbD to In Vivo Evaluation
Pharmacological treatments of central nervous system diseases are always challenging due to the restrictions imposed by the blood–brain barrier: while some drugs can effectively cross it, many others, some antiepileptic drugs among them, display permeability issues to reach the site of action and ex...
Autores principales: | Scioli-Montoto, Sebastian, Sbaraglini, Maria Laura, Cisneros, Jose Sebastian, Chain, Cecilia Yamil, Ferretti, Valeria, León, Ignacio Esteban, Alvarez, Vera Alejandra, Castro, Guillermo Raul, Islan, German Abel, Talevi, Alan, Ruiz, Maria Esperanza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428247/ https://www.ncbi.nlm.nih.gov/pubmed/36059881 http://dx.doi.org/10.3389/fchem.2022.908386 |
Ejemplares similares
-
Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies
por: Muraca, Giuliana, et al.
Publicado: (2023) -
Design, Synthesis, Characterization, and Evaluation of the Anti-HT-29 Colorectal Cell Line Activity of Novel 8-Oxyquinolinate-Platinum(II)-Loaded Nanostructured Lipid Carriers Targeted with Riboflavin
por: Boztepe, Tugce, et al.
Publicado: (2023) -
Early Implementation of QbD in Biopharmaceutical Development: A Practical Example
por: Zurdo, Jesús, et al.
Publicado: (2015) -
Pharmaceutical Development and Design of Thermosensitive Liposomes Based on the QbD Approach
por: Dobó, Dorina Gabriella, et al.
Publicado: (2022) -
QbD Based Media Development for the Production of Fab Fragments in E. coli
por: Kumar, Deepak, et al.
Publicado: (2019)